Gardasil Tied to 16 Additional Deaths

We have long been writing about the many issues—medical and political—linked to <"http://www.yourlawyer.com/topics/overview/gardasil_side_effects">Gardasil. Now, Judicial Watch announced that it just discovered that US <"http://www.yourlawyer.com/topics/overview/gardasil_side_effects">Food and Drug Administration (FDA) records detail 16 new deaths tied to the controversial medication.

Approved in 2006, Gardasil prevents four strains of HPV. As of June 2009, 15 million girls had received Gardasil vaccines and some also reported suffering from adverse reactions that have included dizziness, numbness, and blood clots, among other dangerous, and sometimes even deadly, reactions. Gardasil prevents four strains of HPV, two of which cause 70 percent of all cervical cancers. The other two HPV strains are responsible for about 90 percent of genital warts.

According to existing records, 3,589 adverse reactions have been tied to Gardasil between May 2009 and September 2010, including 213 cases resulting in permanent disability, said Judicial Watch, a public interest group that investigates and prosecutes government corruption.

Judicial Watch just announced that it received the new documents from FDA under the provisions of the Freedom of Information Act (FOIA). The documents detail reports of adverse reactions to Gardasil, including 16 new deaths, which includes four suicides, between May 2009 and September 2010. The FDA also produced 789 “serious” reports, with 213 cases resulting in permanent disability and 25 resulting in a diagnosis of Guillian Barre Syndrome.

Judicial Watch provided the excerpts of the following adverse reports:

• A 19-year-old girl with no medical history except occasional bronchitis received Gardasil and in 53 days, had “Headache, Nausea, dizziness, chilling, tiredness, shortness of breath, complained of chest plain, severe cramps.” She experienced an Acute Cardiac Arrhythmia. Attempts to resuscitate her resulted in a sternal fracture, but were unsuccessful and the patient died. — V. 356938


• A 13-year-old girl was vaccinated on July 17th, 2009. Ten days later, she developed a fever and was treated; however, “the patient did not recover and was admitted to the hospital on [August 8th] … She developed dyspnoea and went into a coma…she expired [that day] at around 9:00 pm. The cause of death was determined as ‘death due to viral fever.’ … This event occurred after 23 days of receiving first dose of Gardasil. — V. 380081


• Thirteen days after vaccination, a 10-year-old girl developed “progressive loss of strength in lower and upper extremities almost totally…. Nerve conduction studies [showed Guillain Barre Syndrome].” Case was “considered to be immediately life-threatening.” — V. 339375


• One mother of a 13-year old girl who died 37 days after receiving the vaccination noted in a report: “I first declined getting her the vaccination but her doctor ensured me that it was safe…” After her daughter complained of a severe headache, no feeling in her foot, and a tingling feeling in her leg, a doctor’s appointment was set for October 23, 2009. “My daughter never made it to Oct[ober] 23rd, which is also her birthday,” the mother noted. “She passed on Oct[ober] 17th, I found her cold, unresponsive in her room at 7am….”

“To say Gardasil has a suspect safety record is a big understatement. These reports are troubling and show that the FDA and other public health authorities may be asleep at the switch,” said Judicial Watch President Tom Fitton. “In the meantime, the public relations push for Gardasil by Merck and politicians on Capitol Hill continues. No one should require this vaccine for young children.”


In 2008, Judicial Watch launched a comprehensive investigation of Gardasil’s safety record. All previous FDA documents uncovered by Judicial Watch, as well as a Judicial Watch special report, entitled “Examining the FDA’s HPV Vaccine Records: Detailing the Approval Process, Side-Effects, Safety Concerns & Marketing Practices of a Large Scale Health Experiment,” are available at www.JudicialWatch.org.

This entry was posted in Pharmaceuticals. Bookmark the permalink.


© 2005-2016 Parker Waichman LLP ®. All Rights Reserved.